Margaret Tooth Sells 978 Shares of Trupanion (NASDAQ:TRUP) Stock

Trupanion, Inc. (NASDAQ:TRUPGet Free Report) CEO Margaret Tooth sold 978 shares of the firm’s stock in a transaction that occurred on Tuesday, August 11th. The shares were sold at an average price of $29.05, for a total value of $28,410.90. Following the completion of the transaction, the chief executive officer owned 175,401 shares of the company’s stock, valued at approximately $5,095,399.05. This represents a 0.55% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Margaret Tooth also recently made the following trade(s):

  • On Monday, May 25th, Margaret Tooth sold 491 shares of Trupanion stock. The stock was sold at an average price of $21.86, for a total value of $10,733.26.

Trupanion Trading Down 1.3%

Shares of Trupanion stock opened at $30.60 on Friday. Trupanion, Inc. has a 12-month low of $21.16 and a 12-month high of $49.90. The stock has a market cap of $1.34 billion, a P/E ratio of 57.74, a P/E/G ratio of 2.23 and a beta of 1.39. The company has a quick ratio of 1.77, a current ratio of 1.77 and a debt-to-equity ratio of 0.24. The business’s 50 day moving average is $25.56 and its 200-day moving average is $26.11.

Trupanion (NASDAQ:TRUPGet Free Report) last released its quarterly earnings data on Wednesday, August 5th. The financial services provider reported $0.16 EPS for the quarter, beating the consensus estimate of $0.11 by $0.05. Trupanion had a return on equity of 5.96% and a net margin of 1.53%.The company had revenue of $392.93 million during the quarter, compared to the consensus estimate of $389.72 million. During the same quarter in the prior year, the firm posted $0.22 EPS. The firm’s revenue for the quarter was up 11.1% compared to the same quarter last year. Equities research analysts predict that Trupanion, Inc. will post 0.59 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

A number of analysts have commented on TRUP shares. Atlantic Securities set a $42.00 price objective on shares of Trupanion in a research report on Wednesday, July 15th. Stifel Nicolaus set a $28.00 price objective on shares of Trupanion in a research note on Friday, June 26th. Zacks Research raised shares of Trupanion from a “hold” rating to a “strong-buy” rating in a report on Friday, July 24th. Finally, Weiss Ratings upgraded shares of Trupanion from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Wednesday. One analyst has rated the stock with a Strong Buy rating, two have assigned a Buy rating and three have issued a Hold rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $41.60.

Get Our Latest Stock Report on TRUP

Institutional Investors Weigh In On Trupanion

A number of large investors have recently added to or reduced their stakes in TRUP. Kelleher Financial Advisors acquired a new stake in Trupanion during the 2nd quarter valued at $42,000. Parallel Advisors LLC increased its holdings in shares of Trupanion by 1,831.9% in the first quarter. Parallel Advisors LLC now owns 1,816 shares of the financial services provider’s stock valued at $47,000 after purchasing an additional 1,722 shares during the last quarter. Kemnay Advisory Services Inc. acquired a new position in shares of Trupanion in the fourth quarter valued at $64,000. Quantbot Technologies LP bought a new position in shares of Trupanion in the second quarter valued at about $89,000. Finally, Advisory Services Network LLC bought a new position in shares of Trupanion in the third quarter valued at about $160,000.

About Trupanion

(Get Free Report)

Trupanion, Inc is a pet medical insurance company that provides comprehensive insurance coverage for cats and dogs. The company’s core offering is a single, customizable medical policy designed to cover veterinary diagnostic tests, surgeries, hospital stays and congenital or hereditary conditions. Trupanion seeks to streamline the claims process by offering direct payment options to participating veterinarians, reducing the need for upfront payments by pet owners.

Founded in 1999 by Darryl Rawlings and headquartered in Seattle, Washington, Trupanion began operations in the early 2000s and has grown its presence through both digital channels and partnerships with veterinary hospitals.

Featured Articles

Insider Buying and Selling by Quarter for Trupanion (NASDAQ:TRUP)

Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.